R&D Systems™ Recombinant Rat PD-L2/B7-DC Fc Chimera Protein

Catalog No.	Quantity
99-94P-L100	100 μg

Catalog No. 99-94P-L100 Supplier R&D Systems™ Supplier No. 9994PL100

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Rat PD-L2/B7-DC Fc Chimera is coated at 1 μg/mL (100 μL/well), the concentration of Recombinant Rat PD-1 Fc Chimera (Catalog # 9814-PD ) that produces 50% optimal binding response is 0.01-0.08 μg/mL

Specifications

• Accession Number: NP_001101052.2
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and EDTA with Trehalose.
• Gene ID (Entrez): 80380
• Molecular Weight (g/mol): M.W. (Observed): 62-73 kDa, reducing conditions; M.W. (theoretical): 49 kDa
• Quantity: 100 μg
• Source: Mouse myeloma cell line, NS0-derived rat PD-L2/B7-DC protein Rat PD-L2 (Leu20-Arg219) (N-terminus) Accession # NP_001101052.2 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Specific Reactivity: PD-L2/B7-DC/PDCD1LG2
• Conjugate: Unconjugated
• Species: Rat
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL aq. soln..
• Buffer: Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and EDTA with Trehalose.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: PD-L2/B7-DC/PDCD1LG2